Esperion Therapeutics
Why Robinhood?
You can watch ESPR and buy or sell other stocks, ETFs, and their options commission-free!About ESPR
Esperion Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of oral therapies for elevated low-density lipoprotein cholesterol. The firm offers NEXLETOL (bempedoic acid) tablets, and NEXLIZET (bempedoic acid and ezetimibe) tablets.
ESPR Key Statistics
Stock Snapshot
The current Esperion Therapeutics(ESPR) stock price is $3.18, with a market capitalization of 818.55M. The stock trades at a price-to-earnings (P/E) ratio of -30.72.
On 2026-08-08, Esperion Therapeutics(ESPR) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Esperion Therapeutics(ESPR) stock has reached 0, versus its average volume of 11.44M.
The stock's 52-week range extends from a low of $1.32 to a high of $4.18.
The stock's 52-week range extends from a low of $1.32 to a high of $4.18.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.